MONTE ROSA THERAPEUTICS INC's ticker is GLUE and the CUSIP is 61225M102. A total of 74 filers reported holding MONTE ROSA THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.43 and the average weighting 0.1%.
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aisling Capital Management LP | 1,472,331 | $7,052,465 | 2.91% |
| NEA Management Company, LLC | 7,692,298 | $36,846,107 | 2.85% |
| Octagon Capital Advisors LP | 812,895 | $3,893,767 | 0.60% |
| Alphabet Inc. | 1,464,015 | $7,012,631 | 0.45% |
| Avoro Capital Advisors LLC | 4,535,000 | $21,722,650 | 0.34% |
| Casdin Capital, LLC | 510,882 | $2,447,125 | 0.27% |
| Baker Brothers Advisors | 4,916,095 | $23,548,095 | 0.14% |
| Corton Capital Inc. | 14,460 | $69,263 | 0.04% |
| ExodusPoint Capital Management, LP | 619,248 | $2,966 | 0.03% |
| CORNERCAP INVESTMENT COUNSEL INC | 27,844 | $133,373 | 0.02% |
| Caption Management, LLC | 240,400 | $1,151,516 | 0.02% |
| UBS OCONNOR LLC | 85,478 | $409,440 | 0.01% |
| Caption Management, LLC | 121,000 | $579,590 | 0.01% |
| Candriam S.C.A. | 135,000 | $646,650 | 0.01% |
| Sarasin & Partners LLP | 65,081 | $311,738 | 0.00% |
| Trexquant Investment LP | 25,657 | $122,897 | 0.00% |
| Tower Research Capital LLC (TRC) | 17,163 | $82,210 | 0.00% |
| PRICE T ROWE ASSOCIATES INC /MD/ | 3,870,547 | $18,541 | 0.00% |
| EXCHANGE TRADED CONCEPTS, LLC | 17,412 | $83,403 | 0.00% |
| FMR LLC | 6,004,833 | $28,763,150 | 0.00% |
External links
This page lists MONTE ROSA THERAPEUTICS INC's shareholders in Q3 2023. To view MONTE ROSA THERAPEUTICS INC's shareholder history, click here.